Feasibility & Efficacy of Enhanced Recovery After Surgery (ERAS) on Length

Status Completed

Clinical Trial Summary

The main goal of ERAS is to enhance the recovery of patients, and this has secondary effects, such reduced length of hospital stay, minimal postoperative complications and lessen readmission rates. ERAS protocols have been shown to be feasible and safe across the world. Although it has been shown to be effective in the developed settings and can potentially reduce the length of hospital stay, and the cost of healthcare in the perioperative period. The multimodal program of ERAS has been less implemented in the low and middle income African countries. Studies done outside Uganda (Egypt and South Africa) have demonstrated that ERAS program can be feasible and yields favorable outcomes in patients.

Clinical Trial Description

The efficacy of ERAS has been demonstrated in resource rich settings but limited evidence is available from resource poor settings. The aim of this study was to determine the feasibility and test efficacy of ERAS in reducing length of post-operative hospital stay and the incidence of postoperative complications compared to the standard of care as the control group.

33 participants above 18 years of age, undergoing laparotomy, were randomly assigned to an intervention (ERAS) arm or to a control (standard surgical care) arm at Mbarara Regional Referral Hospital in Uganda. The ERAS and the control arm had 16 and 17 patients respectively, followed-up 14 days after surgery.

Patients in the ERAS arm had 2.4 days (SD 0.7) of post-operative hospital stay shorter than those in the control arm, p=0.0025 (4.1±0.2 vs 6.5±0.6 respectively). 18.8% of patients in the control arm developed post-operative complications compared to 5.9% in the ERAS arm (Statistical insignificance, p=0.34). ERAS patients passed flatus eight hours earlier than patients in the control arm, and mobilisation out of bed happened 12 hours earlier in the ERAS group p value=0.4.

ERAS is feasible at Mbarara Regional Referral Hospital, and it leads to reduced hospital stay duration but not post-operative complications in laparotomy cases. ;

Study Design

Related Conditions & MeSH terms

Laparotomy

Clinical Trial Details

NCT number	NCT03665376
Study type	Interventional
Source	Mbarara University of Science and Technology
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2017
Completion date	August 15, 2017

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03234543` - Remote Ischemic Conditioning in Abdominal Surgery	N/A
Completed	`NCT03827291` - QL Block With Exparel in Colectomy	Phase 4
Recruiting	`NCT01719796` - Effect of TAP Block on Ventilatory Function Following Abdominal Surgery	Phase 2
Completed	`NCT02596269` - Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia	Phase 2/Phase 3
Completed	`NCT00364741` - Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)	Phase 4
Completed	`NCT01723280` - Supplemental Oxygen - Effect on Occurrence of Subsequent Cancer After Abdominal Surgery (Follow-up of the PROXI Trial)	N/A
Terminated	`NCT00514566` - PDS vs Polyamide for Midline Abdominal Closure	N/A
Recruiting	`NCT06089551` - Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery	Phase 4
Withdrawn	`NCT03966768` - DuraMesh Laparotomy Study	N/A
Recruiting	`NCT04985695` - Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy	N/A
Recruiting	`NCT03739944` - Different Surgical Approaches in Patients of Early-stage Cervical Cancer	Phase 3
Terminated	`NCT01890408` - Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.	Phase 2
Recruiting	`NCT00544583` - Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy	Phase 2/Phase 3
Recruiting	`NCT04256798` - Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery	Phase 3
Recruiting	`NCT03738969` - Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Completed	`NCT03989570` - Transversus Abdominis Plane Block Versus Erector Spinae Plane Block	N/A
Not yet recruiting	`NCT04266535` - TCI vs Manually Controlled Infusion of Propofol
Completed	`NCT04065607` - Indications and Outcome of Laparostomy
Completed	`NCT01040013` - Gut Oxygenation and Laparoscopy	Phase 2
Completed	`NCT00637936` - Respiratory Effects of Perioperative Oxygen During General Anaesthesia	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Feasibility and Efficacy of Enhanced Recovery After Surgery (ERAS) on Length of Stay Among Laparotomy Patients at Mbarara Regional Referral Hospital — ERAS-Lap

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms